UnknownNot Applicable

COVID-19 Induced Telogen Effluvium

Turkey (Türkiye)200 participantsStarted 2021-01-27

Plain-language summary

This study inquires about the development of Telogen effluvium following the SARS-CoV-2 infection

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Sars-CoV-2 infection in the past year Exclusion Criteria: * Other common causes of Telogen effluvium ( such as anemia, iron deficiency, thyroid dysfunction)

What they're measuring

Hair shedding

Timeframe: 3 months

Trial details

NCT IDNCT04834102

SponsorIstanbul Medeniyet University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-27

Contact for this trial

Umut Mert YILDIRIM, Dr.

+905423383842 umutmertyildirim@gmail.com

View on ClinicalTrials.gov More Covid19 trials